Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	38.49	-19.98	-32.48
Graham Fair Price	-0.34	611.65	613.76
PEG	-9684.70	-4.85	-0.05
Price/Book	-0.42	0.78	0.79
Price/Cash Flow	-72.18	13.19	-47.42
Prices/Earnings	4.13	-7.63	-7.95
Price/Sales	-3.24	2.41	2.49
Price/FCF	-72.18	13.19	-47.42
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	430.66	-0.03	< 0.005
Operating Margin	-31.14	-0.11	-0.09
ROA	-5.04	-0.02	-0.02
ROE	-0.02	-0.03	-3.86
ROIC	-0.02	-0.03	-25.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	46.81
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.70	-0.32	54.48
EPS QOQ	-1.61	-0.02	99.02
FCF QOQ	-1.26	4.50	255.95
Revenue QOQ	-0.18	< 0.005	-96.41
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	64.33	41.67	-35.23
Days Sales Outstanding (DSO)	62.24	59.30	-4.72
Inventory Turnover	1.40	2.16	54.39
Debt/Capitalization	0.14	0.14	1.98
Quick Ratio	4.48	3.40	-23.99
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	823.35	805.13	-2.21
Cash	337.68	270.41	-19.92
Capex	-0.42	-0.85	-101.49
Free Cash Flow	-13.64	47.75	249.97
Revenue	259.51	261.15	0.63
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	6.21	5.34	-13.96
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.32	5.36	24.17
Naive Interpretation	Member

06 - Financial Health · Bad

Rating